233 related articles for article (PubMed ID: 33290995)
1. Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.
Cibula D; Dostalek L; Hillemanns P; Scambia G; Jarkovsky J; Persson J; Raspagliesi F; Novak Z; Jaeger A; Capilna ME; Weinberger V; Klat J; Schmidt RL; Lopez A; Scibilia G; Pareja R; Kucukmetin A; Kreitner L; El-Balat A; Pereira GJR; Laufhütte S; Isla-Ortiz D; Toptas T; Gil-Ibanez B; Vergote I; Runnenbaum I
Eur J Cancer; 2021 Jan; 143():88-100. PubMed ID: 33290995
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer).
Dostalek L; Runnebaum I; Raspagliesi F; Vergote I; Dusek L; Jarkovsky J; Cibula D
Int J Gynecol Cancer; 2020 Feb; 30(2):261-264. PubMed ID: 31748245
[TBL] [Abstract][Full Text] [Related]
3. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
4. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
5. Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
Derks M; Groenman FA; van Lonkhuijzen LRCW; Schut PC; Westerveld H; van der Velden J; Kenter GG
Int J Gynecol Cancer; 2017 Jun; 27(5):1015-1020. PubMed ID: 28498252
[TBL] [Abstract][Full Text] [Related]
6. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
7. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
[TBL] [Abstract][Full Text] [Related]
9. Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
Tomita N; Mizuno M; Kondo S; Mori M; Takeshita S; Sakata J; Tsubouchi H; Kodaira T
Int J Gynecol Cancer; 2018 Jul; 28(6):1211-1217. PubMed ID: 29727352
[TBL] [Abstract][Full Text] [Related]
10. Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer.
Barquet-Muñoz SA; Rendón-Pereira GJ; Acuña-González D; Peñate MV; Herrera-Montalvo LA; Gallardo-Alvarado LN; Cantú-de León DF; Pareja R
World J Surg Oncol; 2017 Jan; 15(1):23. PubMed ID: 28088221
[TBL] [Abstract][Full Text] [Related]
11. Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy?
Potter ME; Alvarez RD; Shingleton HM; Soong SJ; Hatch KD
Gynecol Oncol; 1990 Apr; 37(1):78-81. PubMed ID: 2323617
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
16. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
Richard SD; Krivak TC; Castleberry A; Beriwal S; Kelley JL; Edwards RP; Sukumvanich P
Gynecol Oncol; 2008 Apr; 109(1):43-8. PubMed ID: 18234297
[TBL] [Abstract][Full Text] [Related]
17. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
18. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
20. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
